Clamp, A., Oza, A., Lorusso, D., Aghajanian, C., Oaknin, A., Dean, A., Colombo, N., Weberpals, J., Scambia, G., Leary, A., Holloway, R., Amenedo Gancedo, M., Fong, P., Goh, J., O'Malley, D., Armstrong, D., Banerjee, S., García-Donas, J., Swisher, E., Cameron, T., Maloney, L., Goble, S., Coleman, R., & Ledermann, J. (n.d.). effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: an analysis from the phase 3 study ARIEL3. International journal of gynecological cancer, 29, A27–A28. http://access.bl.uk/ark:/81055/vdc_100144731010.0x000016